BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23512990)

  • 1. Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1.
    Huang PH; Chuang HC; Chou CC; Wang H; Lee SL; Yang HC; Chiu HC; Kapuriya N; Wang D; Kulp SK; Chen CS
    Sci Signal; 2013 Mar; 6(267):ra19. PubMed ID: 23512990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.
    Yan R; Chuang HC; Kapuriya N; Chou CC; Lai PT; Chang HW; Yang CN; Kulp SK; Chen CS
    J Med Chem; 2015 Mar; 58(5):2290-8. PubMed ID: 25689347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
    Chern Y; Zhang P; Ju H; Tai IT
    Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
    [No Abstract]   [Full Text] [Related]  

  • 5. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).
    Crotty TM; Nakano T; Stafforini DM; Topham MK
    J Biol Chem; 2013 Jan; 288(3):1439-47. PubMed ID: 23184957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
    Li X; Yang H; Liu J; Schmidt MD; Gao T
    EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHLPP1 gene deletion protects the brain from ischemic injury.
    Chen B; Van Winkle JA; Lyden PD; Brown JH; Purcell NH
    J Cereb Blood Flow Metab; 2013 Feb; 33(2):196-204. PubMed ID: 23072745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death.
    Saxena S; Shukla S; Kakkar P
    Toxicol Appl Pharmacol; 2018 May; 347():92-103. PubMed ID: 29626488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.
    Wang P; Zhou Z; Hu A; Ponte de Albuquerque C; Zhou Y; Hong L; Sierecki E; Ajiro M; Kruhlak M; Harris C; Guan KL; Zheng ZM; Newton AC; Sun P; Zhou H; Fu XD
    Mol Cell; 2014 May; 54(3):378-91. PubMed ID: 24703948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway.
    Kempná P; Reiter E; Arock M; Azzi A; Zingg JM
    J Biol Chem; 2004 Dec; 279(49):50700-9. PubMed ID: 15385541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
    Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
    Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.